Skip to main content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

An International Journal for Oncology and Haematology Professionals


memo - Magazine of European Medical Oncology OnlineFirst articles

10.05.2022 | case report

Immunotherapy pitfall: sarcoid-like reaction mimicking disease progression in advanced melanoma treated with nivolumab

Immunotherapy is the first-line treatment in many solid cancers. Immune system activation leads to specific immune-related adverse events (irAE), which also include the rare sarcoid-like reaction (SLR). In imaging studies SLR can mimic cancerous …

09.05.2022 | case report

Neurotoxicity as a rare side effect of immune checkpoint inhibitors. A case report and review of the literature

Neurotoxicity is a rare but often fatal immune-related adverse event (irAE). Here we report the case of a 73-year-old woman treated with pembrolizumab for metastatic bladder cancer who developed aseptic meningoencephalitis after two courses of …

09.05.2022 | short review

Essential news and practice changing trials in oesophageal, gastroesophageal junction and gastric cancer in 2021

In this short review we aim to summarize the highlights in gastric, gastroesophageal junction and oesophageal cancer in 2021. We will discuss practice changing studies and potential guideline changes based on these trials, with focus on the latest …

Open Access 06.05.2022 | short review

ESMO 2021—my top three abstracts in breast cancer

The congress of the European Society of Medical Oncology (ESMO) that recently took place virtually was marked by highlights in many different cancer types. New therapeutic options especially in metastatic breast cancer will hopefully bring a …

06.05.2022 | original report

High mortality in patients with active malignancy and severe COVID-19

Results from an Austrian multicenter registry during the first period of the COVID-19 pandemic

Since its first reported cases in China in December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world. Mutations in the SARS-CoV‑2 genome led to the emergence of variants associated with higher …

Aktuelle Ausgaben

Über diese Zeitschrift

The focus of the journal "magazine of european medical oncology – memo" is to offer a professional review on current research and development in the field of hematology and oncology relevant for daily practice. Therefore, memo includes editorials and comments, peer-reviewed original reports, short reviews, case reports and controversies, articles explaining the biology of neoplasia and congress reports including qualified comments. As a European journal memo aims at highlighting the local peculiarities of various regions and at being a forum for the presentation of ongoing clinical and basic research.

memo is the Official Journal of the Central European Cooperative Oncology Group (CECOG) and The Austrian Society of Haematology and Oncology (OeGHO).

memo - Magazine of European Medical Oncology
Volume 1/2008 - Volume 15/2022
Springer Vienna
Elektronische ISSN
Print ISSN